Key result
Atrioventricular valve surgery is linked to ~10-fold higher Takotsubo syndrome risk, alongside post-op epinephrine and dobutamine.
Why the study?
Takotsubo syndrome following cardiac surgery is rare but early diagnosis is essential to prevent treatments that may worsen patient outcomes, motivating identification of incidence and risk factors.
Are atrio-ventricular valve surgery and postoperative inotropes associated with an increased risk of Takotsubo syndrome following cardiac surgery?
Case-Control (n=156)
No
Are atrio-ventricular valve surgery and postoperative inotropes associated with an increased risk of Takotsubo syndrome following cardiac surgery?
Odds Ratio: 10.5 (95% CI 2.6–42.5)
p-value: p=0.001
Atrio-ventricular valve surgery and the immediate postoperative use of epinephrine and dobutamine are significant risk factors for developing Takotsubo syndrome after cardiac surgery.
May prompt closer monitoring after atrio-ventricular valve surgery; hypothesis-generating and requires prospective validation.
Background: Takotsubo syndrome following cardiac surgery is a rare occurrence. However, early diagnosis is essential to prevent treatment which could increase the left ventricular outflow tract pressure gradient in patients with Takotsubo syndrome, and lead to cardiogenic shock. Therefore, our study aimed to identify the incidence of Takotsubo syndrome after cardiopulmonary bypass and the associated risk factors and prognosis.Methods: We retrospectively studied 5,773 patients who underwent cardiopulmonary bypass between February 2007 and July 2017. Among these, Takotsubo syndrome was diagnosed in 52 (0.9%). To evaluate the risk factors for Takotsubo syndrome, 104 of the remaining 5,721 patient were randomly selected as the control group (1:2 ratio). Univariate and multivariate logistic regression analyses were used for risk factor analysis. Results: Majority of patients (69.2%) in the Takotsubo syndrome group underwent mitral valve surgery, compared to 32.7% in the control group. The following risk factors of Takotsubo syndrome were identified: atrio-ventricular valve surgery (odds ratio (OR),10.5; 95% confidence interval (CI), 2.6-42.5; P=0.001); and the immediate postoperative use of epinephrine (OR, 3.3; 95%CI, 1.0-10.7; P=0.05) and dobutamine (OR, 4.8; 95%CI, 1.72-13.3; P=0.003). Hypertension was a significant protective factor against Takotsubo syndrome following cardiac surgery (OR, 0.22; 95%CI, 0.06-0.73; P=0.01).Conclusions: Takotsubo syndrome following cardiac surgery is rare. Immediate postoperative use of epinephrine and doputamine, as well as atrio-ventricular valve surgery were factors associated with the development of Takotsubo syndrome.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) conducted a case-control in Takotsubo Syndrome following cardiac surgery (n=156). Atrio-ventricular valve surgery vs. Other cardiac surgeries was evaluated on Development of Takotsubo syndrome (OR 10.5, 95% CI 2.6-42.5, p=0.001). Atrio-ventricular valve surgery was strongly associated with the development of Takotsubo syndrome following cardiac surgery (OR 10.5), along with immediate postoperative use of epinephrine and dobutamine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: